Stockscreener 앱 받기
13.99
8.87%
1.14
시간 외 거래:
14.00
0.010
+0.07%
Polyrizon Ltd 주식(PLRZ)의 최신 뉴스
Polyrizon signs MOU to acquire 51% stake in Arrow Aviation By Investing.com - Investing.com South Africa
Will Polyrizon Ltd. stock hit new highs in YEARQuarterly Trade Report & Smart Money Movement Tracker - mfd.ru
Polyrizon stock rises on potential acquisition of Arrow Aviation By Investing.com - Investing.com South Africa
Polyrizon Intends to Secure Controlling Stake in Profitable Private Jet Operator - The Manila Times
Biotech Polyrizon lines up $5.8M deal for $19M private jet firm - Stock Titan
Polyrizon to develop intranasal formulation of Clearmind’s MEAI drug By Investing.com - Investing.com Nigeria
Clearmind partners with Polyrizon to develop intranasal MEAI formulation By Investing.com - Investing.com Nigeria
Polyrizon Ltd. (PLRZ) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Clearmind Medicine (CMND) Stock: Partners With Polyrizon to Advance Intranasal MEAI Therapy - parameter.io
Polyrizon climbs on Clearmind Deal - Baystreet.ca
Polyrizon to develop intranasal formulation of Clearmind’s MEAI drug - Investing.com
Clearmind Medicine stock surges after Polyrizon intranasal delivery deal By Investing.com - Investing.com Nigeria
Clearmind partners with Polyrizon to develop intranasal MEAI formulation - Investing.com
Clearmind Medicine stock surges after Polyrizon intranasal delivery deal - Investing.com
Polyrizon and Clearmind Partner on Intranasal Non-Hallucinogenic Neuroplastogen MEAI - TipRanks
Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen Formulation - The Manila Times
Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI - The Manila Times
Clearmind Medicine Inc. Partners with Polyrizon Ltd. to Develop Innovative Intranasal Formulation for MEAI in CNS Disorders - Quiver Quantitative
Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic ... - Caledonian Record
Biotechs team up on intranasal, non-hallucinogenic addiction therapy - Stock Titan
Polyrizon shares gain on plan to buy majority stake in private aviation company - MSN
Polyrizon Signs MOU to Acquire 51% Stake in Arrow Aviation - Intellectia AI
Polyrizon Moves to Acquire 51% Stake in Global Private Aviation Firm Arrow Aviation - TipRanks
Polyrizon signs MOU to acquire 51% stake in Arrow Aviation - Investing.com
Polyrizon stock rises after announcing plan to acquire stake in private aviation firm - Investing.com Nigeria
Polyrizon stock rises after announcing plan to acquire stake in private aviation firm By Investing.com - Investing.com South Africa
Polyrizon Intends to Acquire 51% Stake in Global Private Aviation Company - The Manila Times
Biotech firm Polyrizon eyes $19M private jet business - Stock Titan
Aug Setups: Is Polyrizon Ltd stock a value trapDay Trade & Real-Time Volume Spike Alerts - baoquankhu1.vn
Polyrizon stock rises on FDA submission for PL-16 viral blocker - Investing.com Nigeria
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Surprises Report: Can Polyrizon Ltd beat the S P 5002025 Market WrapUp & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Sell Signal: Can Polyrizon Ltd disrupt its industry2025 Price Targets & Low Volatility Stock Recommendations - baoquankhu1.vn
Polyrizon begins usability study for intranasal allergy blocker By Investing.com - Investing.com Australia
Technical Analysis: Will Polyrizon Ltd outperform its industry peersJuly 2025 Earnings & Free Community Supported Trade Ideas - baoquankhu1.vn
Polyrizon Launches FDA-Aligned Usability Study for NASARIX Allergy Blocker - TipRanks
Polyrizon begins usability study for intranasal allergy blocker - Investing.com
Polyrizon Advances Regulatory Path with Initiation of Usability Study Program for NASARIX™ Allergy Blocker - The Manila Times
New nasal allergy blocker moves closer to human trials with FDA-guided study - Stock Titan
How rising interest rates impact Polyrizon Ltd. stockJuly 2025 Patterns & Expert Approved Momentum Ideas - bollywoodhelpline.com
Polyrizon’s PL-14 shows strong pre-clinical allergen-blocking advantage over standard nasal barrier - MSN
Polyrizon recives Nasdaq delisting notice - MSN
Polyrizon explores investments in defense, aviation and AI sectors By Investing.com - Investing.com Nigeria
Polyrizon Ltd to explore revenue-generating investment opportunities in high-growth sectors - marketscreener.com
Polyrizon to Explore Revenue-Generating Investment Opportunities in High-Growth Sectors, Leveraging Strong Cash Position and Debt-Free Balance Sheet - manilatimes.net
Polyrizon Ltd To Explore Revenue-Generating Investment Opportunities In High-Growth Sectors - TradingView
User - FinancialContent
Polyrizon (PLRZ) Stock Explodes on Naloxone Hydrogel Breakthrough and PL‑14 Upscaling – What Investors Should Know Now - TechStock²
1.24%
0.19%
자본화:
|
볼륨(24시간):